Comparative enhancement of curcumin cytotoxic photodynamic activity by nanoliposomes and gold nanoparticles with pharmacological appraisal in HepG2 cancer cells and Erlich solid tumor model

Fadel, Maha; Kassab, Kawser; Abd El Fadeel, Doaa A; Nasr, Maha; El Ghoubary, Nayera Mohamed;

Abstract


Curcumin is a natural pigment that generates singlet oxygen upon light excitation, hence it can be used as a photosensitizer in photodynamic therapy. The extremely low water solubility and poor systemic bioavailability make curcumin a challenging molecule to be used clinically. In this study, two nanocarrier systems for curcumin were prepared and characterized; nanoliposomes and polyvinyl pyrrolidone-capped gold nanoparticles. The dark and photocytotoxicity were investigated as a function of light fluence rate (100 and 200 mW/cm2) on HepG2 cancer cells. In vivo Erlich tumor model was developed and comparison of the tumor volume, survival rate, and histopathological alterations was made for the two nanocarriers. Results showed that both curcumin nanocarriers were successfully prepared and characterized. Light irradiation was able to augment the cytotoxicity of both curcumin liposomes and gold nanoparticles, with the former being superior in cytotoxicity compared to the latter. The tumor size was almost diminished 1 month post-photodynamic treatment for both systems with regression in the number of tumor cells upon histopathological evaluation, with curcumin liposomes producing better tumor regression than gold nanoparticles with comparable survival rate. Liposomes were confirmed to be superior to gold nanoparticles as a photodynamic treatment modality for cancer.


Other data

Title Comparative enhancement of curcumin cytotoxic photodynamic activity by nanoliposomes and gold nanoparticles with pharmacological appraisal in HepG2 cancer cells and Erlich solid tumor model
Authors Fadel, Maha; Kassab, Kawser; Abd El Fadeel, Doaa A; Nasr, Maha ; El Ghoubary, Nayera Mohamed
Keywords Curcumin;cancer;gold nanoparticles;liposomes;photodynamic therapy
Issue Date Nov-2018
Journal Drug development and industrial pharmacy 
Volume 44
Issue 11
Start page 1809
End page 1816
ISSN 0363-9045
1520-5762
DOI 10.1080/03639045.2018.1496451
PubMed ID 29969300

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 8 in pubmed
Citations 43 in scopus


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.